Page last updated: 2024-10-24

camostat and Chronic Kidney Failure

camostat has been researched along with Chronic Kidney Failure in 1 studies

camostat : A benzoate ester resulting from the formal condensation of the carboxy group of 4-guanidinobenzoic acid with the hydroxy group of 2-(dimethylamino)-2-oxoethyl (4-hydroxyphenyl)acetate. It is a potent inhibitor of the human transmembrane protease serine 2 (TMPRSS2) and its mesylate salt is currently under investigation for its effectiveness in COVID-19 patients.

Research Excerpts

ExcerptRelevanceReference
"The number of the chronic renal failure (CRF) patients is increasing explosively."1.38Effect of a serine protease inhibitor on the progression of chronic renal failure. ( Adachi, M; Hayata, M; Kakizoe, Y; Kitamura, K; Miyoshi, T; Mizumoto, T; Morinaga, J; Onoue, T; Sakai, Y; Shiraishi, N; Tomita, K; Uchimura, K; Ueda, M; Yamazoe, R, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hayata, M1
Kakizoe, Y1
Uchimura, K1
Morinaga, J1
Yamazoe, R1
Mizumoto, T1
Onoue, T1
Ueda, M1
Shiraishi, N1
Adachi, M1
Miyoshi, T1
Sakai, Y1
Tomita, K1
Kitamura, K1

Other Studies

1 other study available for camostat and Chronic Kidney Failure

ArticleYear
Effect of a serine protease inhibitor on the progression of chronic renal failure.
    American journal of physiology. Renal physiology, 2012, Oct-15, Volume: 303, Issue:8

    Topics: Animals; Creatinine; Disease Progression; Esters; Gabexate; Guanidines; Kidney; Kidney Failure, Chro

2012